We are live on
!
Find out more
PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Est. Return
55.9%
This Fund
S&P 500
This Quarter
Est. Return
+4.91%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.3B
AUM Growth
-$16.8M
(-0.32%)
Cap. Flow
-$266M
Cap. Flow
% of AUM
-5.01%
Top 10 Holdings %
Top 10 Hldgs %
22.18%
Holding
297
New
35
Increased
74
Reduced
86
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$60.5M |
| 2 |
S&P Global
SPGI
|
+$52.3M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$41.3M |
| 4 |
AGN
Allergan plc
AGN
|
+$38.2M |
| 5 |
LVNTA
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
|
+$37.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$98.3M |
| 2 |
Eli Lilly
LLY
|
+$54.1M |
| 3 |
Apple
AAPL
|
+$51.2M |
| 4 |
Fidelity National Information Services
FIS
|
+$42.9M |
| 5 |
Stryker
SYK
|
+$40.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.18% |
| 2 | Financials | 21.66% |
| 3 | Technology | 21.39% |
| 4 | Communication Services | 9.45% |
| 5 | Consumer Discretionary | 5.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alphabet (Google) Class C
GOOG
$3.9T
| $175M | 3.29% |
5,045,060
+59,480
| +1% | +$2.14M |
|
|
2
Pfizer
PFE
$140B
| $163M | 3.08% |
4,878,532
+1,894,620
| +63% | +$60.5M |
|
3
Chubb
CB
$140B
| $146M | 2.76% |
1,118,716
-17,313
| -2% | -$2.13M |
|
|
4
Apple
AAPL
$4.89T
| $126M | 2.38% |
5,271,860
-2,062,096
| -28% | -$51.2M |
|
5
Meta Platforms (Facebook)
META
$1.51T
| $111M | 2.09% |
969,756
+21,100
| +2% | +$2.43M |
|
|
6
Johnson & Johnson
JNJ
$634B
| $99M | 1.87% |
816,119
-865,400
| -51% | -$98.3M |
|
7
Berkshire Hathaway Class B
BRK.B
$1.07T
| $90.5M | 1.71% |
625,391
-12,498
| -2% | -$1.79M |
|
|
8
Alphabet (Google) Class A
GOOGL
$3.91T
| $90M | 1.7% |
2,558,720
+50,700
| +2% | +$1.86M |
|
9
Medtronic
MDT
$107B
| $87.9M | 1.66% |
1,012,538
+209,181
| +26% | +$16.9M |
|
10
Markel Group
MKL
$25B
| $87.2M | 1.65% |
91,544
-1,152
| -1% | -$1.07M |
|
11
Arch Capital
ACGL
$36.1B
| $84M | 1.59% |
3,501,525
-18,843
| -0.5% | -$445K |
|
12
Microsoft
MSFT
$2.84T
| $82.4M | 1.56% |
1,610,792
-351,074
| -18% | -$18.2M |
|
13
Suncor Energy
SU
$77.7B
| $78.9M | 1.49% |
2,467,087
+823,425
| +50% | +$22.6M |
|
14
JPMorgan Chase
JPM
$939B
| $75.3M | 1.42% |
1,211,051
+24,029
| +2% | +$1.5M |
|
15
Visa
V
$677B
| $74.5M | 1.41% |
1,004,034
-37,832
| -4% | -$2.96M |
|
|
VR
16
DELISTED
Validus Hold Ltd
VR
| $71M | 1.34% |
1,461,897
+8,534
| +0.6% | +$400K |
|
17
Intel
INTC
$464B
| $69M | 1.3% |
2,103,433
-155,308
| -7% | -$4.87M |
|
|
BCR
18
DELISTED
CR Bard Inc.
BCR
| $67.1M | 1.27% |
285,293
-52,699
| -16% | -$11.4M |
|
19
Citigroup
C
$222B
| $64.3M | 1.21% |
1,516,811
-131,477
| -8% | -$5.81M |
|
20
Elevance Health
ELV
$81.9B
| $63.7M | 1.2% |
485,248
+25,931
| +6% | +$3.55M |
|
21
PepsiCo
PEP
$186B
| $63.4M | 1.2% |
598,908
+34,368
| +6% | +$3.55M |
|
22
Amdocs
DOX
$5.53B
| $60.6M | 1.14% |
1,050,503
-22,976
| -2% | -$1.32M |
|
|
LVNTA
23
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
| $58.9M | 1.11% |
1,588,931
+977,986
| +160% | +$37.2M |
|
24
Amazon
AMZN
$2.5T
| $56.1M | 1.06% |
1,567,340
-165,720
| -10% | -$5.61M |
|
25
Booz Allen Hamilton
BAH
$8.7B
| $55.3M | 1.04% |
1,865,589
+32,572
| +2% | +$932K |
|
Similar funds
ECM
FAAS
WAM
FS
NIMC
TI
VIM
PS
Polar Capital's Q2 2016 Portfolio in Review
As of Q2 2016, Polar Capital held 297 positions worth $5.3B, down 0.32% from $5.32B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Polar Capital withdrew a net $266M in Q2 2016, closing 35 positions and reducing 86 holdings. Its most notable exit was Stryker, an estimated $40.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
Against the trend, Polar Capital opened a new position in S&P Global worth $52.2M.
- Polar Capital's largest Q2 2016 buy was S&P Global: 487,049 shares worth $52.2M.
- Polar Capital added most to Pfizer in Q2 2016, an estimated $60.5M increase.
- Polar Capital's biggest Q2 2016 reduction was Johnson & Johnson, cutting an estimated $98.3M.
- Polar Capital fully exited Stryker in Q2 2016, selling an estimated $40.2M.
- Polar Capital's ten largest holdings make up 22% of its $5.3B portfolio in Q2 2016.
- Polar Capital opened 35 new positions and closed 35 in Q2 2016.
- Polar Capital's portfolio value fell 0.32% quarter-over-quarter to $5.3B.
Based on Polar Capital's 13F filing for Q2 2016, filed 15 Aug 2016.